Acro Biomedical Co., Ltd.
ACBM
$0.0007
-$0.1043-99.33%
| 06/30/2023 | 03/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -11.27% | 0.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -20.20% | -6.76% | |||
| Operating Income | 20.20% | -1.77% | |||
| Income Before Tax | 20.20% | -1.77% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 20.20% | -1.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 20.20% | -1.77% | |||
| EBIT | 20.20% | -1.77% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 20.24% | -1.83% | |||
| Normalized Basic EPS | 20.14% | -1.71% | |||
| EPS Diluted | 20.24% | -1.83% | |||
| Normalized Diluted EPS | 24.94% | -1.71% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 6.44% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
